Skip to content
Loading…
Revolution Medicines won US approval for a breakthrough pill that lengthens the lives of patients with advanced pancreatic cancer, a major advance against one of the hardest-to-treat tumor types. The once-daily drug carries a list price of more than $475,000 a year, making it…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.